Cynthia A. Mattingly

Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP

Xiaowei Dong, Cynthia A. Mattingly, Michael T. Tseng et al. · Cancer Research · 2009 · 285 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +12

Overexpression of manganese superoxide dismutase protects against mitochondrial‐initiated poly(ADP‐ribose) polymerase‐mediated cell death

Kelley K. Kiningham, Terry D. Oberley, Si‐Min Lin et al. · The FASEB Journal · 1999 · 99 citations

Life Sciences, Biochemistry, Cell Biology +17

Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization

Xiaowei Dong, Cynthia A. Mattingly, Michael T. Tseng et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2008 · 96 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +14

Increased tumorigenicity in the human pancreatic cell line MIA PaCa‐2 Is associated with an aberrant regulation of an IGF‐1 autocrine loop and lack of expression of the TGF‐β type RII receptor

James W. Freeman, Cynthia A. Mattingly, William E. Strodel · Journal of Cellular Physiology · 1995 · 58 citations

Medicine, Cancer Biology, Oncology +16

Generation of New Landomycins with Altered Saccharide Patterns through Over‐expression of the Glycosyltransferase Gene <i>lanGT3</i> in the Biosynthetic Gene Cluster of Landomycin A in <i>Streptomyces cyanogenus</i> S‐136

Andriy Luzhetskyy, Martha Luzhetska, Cynthia A. Mattingly et al. · ChemBioChem · 2006 · 51 citations · Full text

Life Sciences, Biochemistry, Microbiology +17